Ultragenyx Pharmaceutical
RARE
#5292
Rank
NZ$2.94 B
Marketcap
NZ$28.92
Share price
-1.12%
Change (1 day)
-49.56%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: NZ$2.94 Billion

As of November 2026 Ultragenyx Pharmaceutical has a market cap of NZ$2.94 Billion. This makes Ultragenyx Pharmaceutical the world's 5292th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.94 B-48.25%
2025NZ$5.69 B-19.89%
2024NZ$7.10 B14.5%
2023NZ$6.20 B21.37%
2022NZ$5.11 B-39.04%
2021NZ$8.39 B-33.88%
2020NZ$12.69 B246.03%
2019NZ$3.66 B11.26%
2018NZ$3.29 B18.54%
2017NZ$2.78 B-32.94%
2016NZ$4.14 B-34.92%
2015NZ$6.37 B256.34%
2014NZ$1.78 B

End of Day market cap according to different sources

On Nov 16th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

NZ$2.94 Billion
by Nasdaq info icon info icon
NZ$2.94 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
NZ$1.41 B-51.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$1.49 B-49.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$8.27 B 180.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$20.42 B 593.10%๐Ÿ‡บ๐Ÿ‡ธ USA